Structural and Immunological Characterization of the Intracellular Forms of an Abundant 68000 M r Human Cytomegalovirus Protein

References

1. Alford C. A., Stagno S., Pass R. F. 1980; Natural history of perinatal cytomegalovirus infection. In Perinatal Infections 77 pp. 125–147 New York: Elsevier/North-Holland;
   [Google Scholar]
2. Benko D., Gibson W. 1986; Primate cytomegalovirus glycoproteins: lectin-binding properties and sensitivities to glycosidases. Journal of Virology 59:703–713
   [Google Scholar]
3. Britt W. J. 1984; Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135:369–378
   [Google Scholar]
4. Britt W. J., Auger D. 1985; Identification of a 65,000 dalton virion envelope protein of human cytomegalovirus. Virus Research 4:31–36
   [Google Scholar]
5. Britt W. J., Auger D. 1986a; Synthesis and processing of the envelope gp55-l 16 complex of human cytomegalovirus. Journal of Virology 58:185–191
   [Google Scholar]
6. Britt W. J., Auger D. 1986b; Human cytomegalovirus virion-associated protein with kinase activity. Journal of Virology 59:185–188
   [Google Scholar]
7. Campbell M. E., Palfreyman J. W., Preston C. M. 1984; Identification of herpes simplex virus DNA sequences which encode a transacting polypeptide responsible for stimulation of immediate early transcription. Journal of Molecular Biology 180:1–19
   [Google Scholar]
8. Chesebro B., Wehrly K., Cloyd M., Britt W. J., Portis J., Collins J., Nishio J. 1981; Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens. Virology 112:131–144
   [Google Scholar]
9. Clark B. R., Zaia J., Balce-Directo L., Ting Y. P. 1984; Isolation and partial chemical characterization of 64,000 dalton glycoprotein of human cytomegalovirus. Journal of Virology 49:279–282
   [Google Scholar]
10. Forman S. J., Zaia J., Clark B., Wright C., Mills B., Pottahil R., Racklin B., Gallagher M., Welte K., Blume K. 1985; A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen. Journal of Immunology 134:3391–3395
    [Google Scholar]
11. Geballe A. P., Leach F. S., Mocarski E. S. 1986; Regulation of cytomegalovirus late gene expression: genes are controlled by post-transcriptional events. Journal of Virology 57:864–874
    [Google Scholar]
12. Gibson W. 1983; Protein counterparts of human and simian cytomegaloviruses. Virology 128:391–406
    [Google Scholar]
13. Gibson W., Irmiere A. 1984; Selection of particles and proteins for use as human cytomegalovirus subunit vaccines. In CMV: Pathogenesis and Prevention of Human Infection, March of Dimes Birth Defects Original Articles Series 20 pp. 305–324 Plotkin S. A., Michelson S., Pagano J. S., Rapp F. Edited by New York: Alan R. Liss;
    [Google Scholar]
14. Godowski P. J., Knipe D. 1985; Identification of a herpes simplex virus function that represses late gene expression from parental viral genomes. Journal of Virology 55:357–365
    [Google Scholar]
15. Ho M. 1982 Cytomegalovirus: Biology and Infection New York: Plenum Press;
    [Google Scholar]
16. Honess R. W., Roizman B. 1974; Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. Journal of Virology 14:8–19
    [Google Scholar]
17. Honess R. W., Roizman B. 1975; Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proceedings of the National Academy of Sciences, U.S.A 72:1276–1280
    [Google Scholar]
18. Kim K. S., Sapienza V. S., Chen C. J., Wisniewski H. 1983; Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus. Journal of Clinical Microbiology 18:331–343
    [Google Scholar]
19. Lemaster S., Roizman B. 1980; Herpes simplex virus phosphoproteins. II. Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virion. Journal of Virology 35:798–811
    [Google Scholar]
20. Pereira L., Hoffman M., Cremer N. 1982a; Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera. Infection and Immunity 36:933–942
    [Google Scholar]
21. Pereira L., Hoffman M., Gallo D., Cremer N. 1982b; Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify crossreactive determinants. Infection and Immunity 36:924–932
    [Google Scholar]
22. Pereira L., Hoffman M., Tatsuno M., Dondero D. 1984; Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. Virology 139:73–86
    [Google Scholar]
23. Ruger B., Klages S., Walla B., Albrecht J., Fleckenstein B., Tomlinson P., Barrell B. 1987; Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. Journal of Virology 61:446–453
    [Google Scholar]
24. The T. H., Klein G., Langehuysen M. 1974; Antibody reactions to virus specific early antigens (EA) in patients with cytomegalovirus infection. Clinical and Experimental Immunology 16:1–12
    [Google Scholar]
25. Weiner D. w., Gibson W., Fields K. L. 1985; Anti-complement immunofluorescence establishes nuclear localization of human cytomegalovirus matrix protein. Virology 147:19–28
    [Google Scholar]
26. Zaia J., Forman S. J., Ting Y. P., Vanderwal-Urbina E., Blume K. G. 1986; Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. Journal of Infectious Diseases 153:780–787
    [Google Scholar]